research COVID-19 and Skin: A New Chapter in Dermatology
COVID-19 can cause skin problems directly or from using protective gear and sanitizers, and knowing this can help treat patients better.
Search
for
Sort by
Research
360-390 / 1000+ results research Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
research This Month in JAAD International: November 2021: COVID-19 and Hair Loss
COVID-19 patients often experience temporary hair loss and scalp pain.
research A Comment on Psychological Distress and Women’s Hair Loss Related to the COVID-19 Pandemic
The COVID-19 pandemic has increased hair loss and psychological distress in women.
research Race, Ethnicity, and Comorbidities Are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID-19 Pandemic
Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.
research Cutaneous Manifestations of COVID-19
Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.
research A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
COVID-19 may trigger sudden temporary hair loss.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research Telogen Effluvium: Long-Term COVID-19 Symptom
COVID-19 recovery can lead to temporary hair loss called telogen effluvium.
research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'
Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
research Alopecia and Grey Hair Are Associated with COVID-19 Severity
Having a lot of gray hair and hair loss are linked to more severe COVID-19.
research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience
Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.
research Platelet-Rich Plasma Therapy with Excellent Results in the Treatment of Post-Infectious Telogen Effluvium
Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.
research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case Series
PRP treatment effectively reduces hair loss after COVID-19.
research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.
research Reply to: Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'
High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
research SARS-CoV-2 and Androgenic Alopecia: Exploring Links
Possible link between COVID-19 and hair loss; more research needed.
research Diffused Alopecia Followed by Severe Acute Respiratory Syndrome Coronavirus-2 Infection
A woman's hair loss improved with treatment after a COVID-19 infection.
research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients
COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.
research COVID-19 Infection: Impact on Hair
COVID-19 may cause increased and quicker hair loss compared to other infections.
research Analysis and Clinical Determinants of Post-Covid-19 Syndrome in the Lombardy Region: Evidence From a Longitudinal Cohort Study
The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.
research Covid-19 and Male Androgenetic Alopecia: Systematic Investigation of a Potential Epidemiological and Genetic Association
No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.
research Hospitalized COVID-19 Androgenetic Alopecia JAAD Data Age Group Comparison with Other References
research Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects
COVID-19 can cause a temporary hair loss condition.
research ESDR072 – COVID-19 and Male Androgenetic Alopecia: Systematic Investigation of a Potential Epidemiological and Genetic Association
research Hair Loss After SARS-CoV-2 Infection
Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.
research COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium: The Role of Proteoglycan Replacement Therapy with Nourkrin in Clinical Treatment of COVID-19 Associated Hair Loss
COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.
research Telogen Effluvium: A 360 Degree Review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.